NOS3 and COVID-19: Interestingly, COVID-19 severe patients show the inhibition of endothelial nitric oxide synthase (eNOS), leading to a concurrent deficiency in nitric oxide (NO) production and an up-regulation of arginase that, instead, favors the production of ornithine and its metabolites from arginine over the synthesis of NO [17,18].